Journal of neuroimmunology

publication venue for

COVID-19, HHV6 and MOG antibody: A perfect storm. 2021
Synergistic effects of alcohol and HIV TAT protein on macrophage migration and neurotoxicity.. 368. 2022
Characterization, isolation, and in vitro culture of leptomeningeal fibroblasts.. 361. 2021
Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis.. 309. 2017
Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.. 303. 2016
Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.. 288. 2015
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.. 283. 2015
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.. 276. 2014
Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.. 255. 2012
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.. 254. 2012
Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.. 233. 2010
Gene expression profiling in nerve biopsy of vasculitic neuropathy.. 225. 2010
NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS.. 222. 2010
TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.. 216. 2009
Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex.. 217. 2009
Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment.. 210. 2009
Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside.. 177. 2006
BDNF: a missing link between sympathetic dysfunction and inflammatory disease?. 175. 2006
Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.. 171. 2005
CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism.. 164. 2005
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.. 164. 2005
Gene expression profiling in chronic inflammatory demyelinating polyneuropathy.. 159. 2004
Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue.. 159. 2004
The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis.. 148. 2004
Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni.. 146. 2004
Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.. 144. 2003
Serum anti-Fas antibody levels in amyotrophic lateral sclerosis.. 142. 2003
Ganglioside reactive antibodies in the neuropathy associated with celiac disease.. 127. 2002
Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.. 110. 2000
CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.. 109. 2000
Antibodies to chondroitin sulfates A, B, and C: clinico-pathological correlates in neurological diseases.. 108. 2000
Antigen presenting capacity of brain microvasculature in altered peptide ligand modulation of experimental allergic encephalomyelitis.. 93. 1999
Involvement of capsaicin sensitive primary afferents in thymulin-induced hyperalgesia.. 91. 1998
Antibodies to chondroitin sulfate C: a new detection assay and correlations with neurological diseases.. 84. 1998
Altered peptide ligand modulation of experimental allergic encephalomyelitis: immune responses within the CNS.. 81. 1998
Immunization of guinea pigs with human choline acetyltransferase induces selective lower motoneuron destruction.. 78. 1997
Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides.. 78. 1997
Experimental immune-mediated damage of septal cholinergic neurons.. 77. 1997
The effect of thymectomy on autoreactive T- and B-lymphocytes in myasthenia gravis.. 74. 1997
Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis.. 58. 1995
IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses.. 58. 1995
Experimental autoimmune nigral damage in guinea pigs.. 57. 1995
Affinity studies of human anti-MAG antibodies in neuropathy.. 52. 1994
Somatically mutated member of the human V lambda VIII gene family encodes anti-myelin-associated glycoprotein (MAG) activity.. 51. 1994
Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells.. 50. 1994
Dopamine receptors on human T- and B-lymphocytes.. 45. 1993
Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravis.. 42. 1993
Vimentin-crossreactive antibodies induce cell death in primary cultures of embryonic spinal cord.. 42. 1993
DNA sequence analysis and comparison of the variable heavy and light chain regions of two IgM, monoclonal, anti-myelin associated glycoprotein antibodies.. 36. 1992
Cyclophosphamide alters the clinical and pathological expression of experimental autoimmune gray matter disease.. 34. 1991
Identification of glycoconjugates which are targets for anti-Gal(beta 1-3)GalNAc autoantibodies in spinal motor neurons.. 34. 1991
Malignant glioma modulation of immune function: relative contribution of different soluble factors.. 33. 1991
The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation.. 31. 1991
Molecular cloning of a human immunoglobulin heavy chain variable (vh) region with anti-myelin-associated glycoprotein activity.. 30. 1990
Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease.. 27. 1990
Autoantigens in human neuroblastoma cells.. 26. 1990
Molecular cloning of a human immunoglobulin heavy chain variable (VH) region with anti-myelin-associated glycoprotein activity.. 26. 1990
Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins.. 23. 1989
Specificity of human anti-neurofilament autoantibodies.. 21. 1989
Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease.. 21. 1989
Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNAc and Gal(beta 1-3)GlcNAc.. 19. 1988
Immune reactive C3d on the surface of myelin sheaths in neuropathy.. 18. 1988
Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects.. 17. 1988
Characterization of oligosaccharides that bind to human anti-MAG antibodies and to the mouse monoclonal antibody HNK-1.. 12. 1986
Glycosaminoglycan antigens in peripheral nerve. Studies with antibodies from a patient with neuropathy and monoclonal gammopathy.. 12. 1986
Correspondence: Electroconvulsive therapy in N-methyl-D-aspartate receptor encephalitis. 2024
Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models. 2014
Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. 2021
Insights into CCL21's roles in immunosurveillance and immunotherapy for gliomas. 2017
Exploring the role of inflammation in the malignant transformation of low-grade gliomas. 2016

VIVO Weill Cornell Medical College

Journal of neuroimmunology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)